Rizenta Tablet (Linagliptin)
Linagliptin Micronized 5mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
MFDS item code 201901280 · Approved 2019.02.28
This product's status changed to Approval withdrawn on 2025.01.09. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to help control blood glucose levels in patients with type 2 diabetes. It can be administered alone as an initial treatment for diabetes and is also used in conjunction with Metformin when blood glucose control is difficult with Metformin alone. Additionally, it can be used effectively along with sulfonylurea monotherapy or insulin therapy for better blood glucose management. This medication also helps when blood glucose control is insufficient while using both Metformin and sulfonylurea. If blood glucose control is not adequate when used in combination with Empagliflozin and Metformin, this medication can be added. Thus, it is used in combination with various drugs to improve blood glucose control.
The recommended dose of this medication is 5mg once daily. It may be administered regardless of meals. When coadministered with insulin or an insulin secretagogue (such as a sulfonylurea), a lower dose of insulin and insulin secretagogue may be needed to minimize the risk of hypoglycemia.
This medication should not be used in patients who are allergic to the active ingredient or other components of this medication. It should also not be given to patients with type 1 diabetes or diabetic ketoacidosis. When used with insulin or sulfonylurea drugs that can induce hypoglycemia, the risk of hypoglycemia may increase, so dosage adjustment may be necessary. Caution should be exercised in patients with heart failure classified as NYHA functional class I-II, and it is not recommended for class III-IV patients. Acute pancreatitis may occur; if severe abdominal pain persists, discontinue the medication immediately and consult a doctor. A skin condition called bullous pemphigoid may appear, and if symptoms such as blisters or sores occur, inform the doctor immediately, and consider discontinuing the medication if necessary. Hypoglycemic symptoms may occur during treatment with this medication, so careful monitoring of blood glucose changes is required. Severe joint pain may occur, and if symptoms appear, consideration should be given to discontinuing the medication. Its safety during pregnancy has not been established, so it is not recommended for use, and caution is also needed during breastfeeding. It is not recommended for children under 10 years of age; in adolescents over 10 years, a safety profile similar to that of adults is observed. Elderly patients can use it without special dose adjustments. Patients with renal or hepatic impairment can also be administered without dose adjustments. In cases of overdose, since the drug may not be well absorbed in the gastrointestinal tract, general supportive therapy such as gastric lavage may be required if necessary. Medications should be stored out of the reach of children and should not be transferred to other containers.
Hypoglycemia, nasopharyngitis, hypersensitivity, angioedema, urticaria, hypertriglyceridemia, hyperlipidemia, cough, pancreatitis, constipation, oral ulcer, rash, pemphigus vegetans, joint pain with severe symptoms and disability, rhabdomyolysis, weight gain, increased lipase, increased amylase, dyspepsia, edema, facial edema, peripheral edema, weight loss, increased appetite, constipation, abdominal pain, enterocolitis, bowel obstruction, gastroenteritis, shingles, cystitis, acute pyelonephritis, bronchitis, vestibular neuronitis, sepsis, pneumonia, decreased appetite, dehydration, hyperglycemia, cerebral infarction, speech disorder, Alzheimer’s dementia, chest pain, fever, facial swelling, fatigue, death, chronic obstructive pulmonary disease, asthma, diabetic foot, skin lesions, metastasis to the liver, acute leukemia, basal cell carcinoma, non-small cell lung cancer, malignant pericardial effusion, stomach cancer, rectal cancer, pancreatic cancer, meniscal injury, pneumoconiosis, congestive heart failure, angina, acute myocardial infarction, unstable angina, cardiac arrest, diabetic retinopathy, acute kidney injury, end-stage kidney disease, acute cholangitis, acute cholecystitis, cholangitis, cholelithiasis, dizziness, renal transplant failure, anemia, nausea, diarrhea, vomiting, gastroesophageal reflux disease, gastritis, viral upper respiratory infection, upper respiratory infection, gastroenteritis, shingles, cystitis, hypercholesterolemia, inadequate control of diabetes, malnutrition, hyponatremia, dizziness, sensory impairment, chest discomfort, weakness, pain, nosebleed, oropharyngeal pain, speech difficulty, allergic rhinitis, exercise-induced dyspnea, wet cough, runny nose, pulmonary mass, joint pain, osteoporosis, arthropathy, musculoskeletal discomfort, myositis, myalgia, soft tissue mass, postmenopausal osteoporosis, rotator cuff syndrome, increased serum triglycerides, increased urine albumin/creatinine ratio, positive urine leukocytes, decreased hemoglobin, increased serum potassium, increased serum creatinine, increased serum creatine phosphokinase, increased ALT, male pattern baldness, diabetic foot syndrome, hyperhidrosis, hair loss, dermatitis, anxiety, mood disorder, insomnia, depression, contusion, bone contusion, concussion, bone fracture, hand fracture, laceration, palpitations, dry eye, glaucoma, cataract, ocular discomfort, allergic conjunctivitis, polyuria, proteinuria, stress urinary incontinence, hematuria, hypotension, flushing, hepatic steatosis, hearing loss, erectile dysfunction, goiter, benign prostatic hyperplasia
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly closed container. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius to preserve the effectiveness of the medication for an extended period.
Bright red circular film-coated tablets
30 tablets (10 tablets/Alu-Alu*3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Linagliptin Micronized 5mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Linagliptin Micronized 5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Linagliptin Micronized 5mg
Tablet · Prescription medication
Genewon Science Co., Ltd.

Linagliptin Micronized 5mg
Tablet · Prescription medication
Genupharm Co., Ltd.

Linagliptin Micronized 5mg
Tablet · Prescription medication
Aprogen Pharmaceuticals, Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.